These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 32332985)

  • 1. Parkinson disease and the immune system - associations, mechanisms and therapeutics.
    Tan EK; Chao YX; West A; Chan LL; Poewe W; Jankovic J
    Nat Rev Neurol; 2020 Jun; 16(6):303-318. PubMed ID: 32332985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies.
    Fleming SM; Davis A; Simons E
    Neuropharmacology; 2022 Jan; 202():108870. PubMed ID: 34742741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing the immune system for the treatment of Parkinson's disease.
    Vedam-Mai V
    Brain Res; 2021 May; 1758():147308. PubMed ID: 33524380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periphery and brain, innate and adaptive immunity in Parkinson's disease.
    Harms AS; Ferreira SA; Romero-Ramos M
    Acta Neuropathol; 2021 Apr; 141(4):527-545. PubMed ID: 33555429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease.
    Contaldi E; Magistrelli L; Comi C
    Handb Clin Neurol; 2023; 193():67-93. PubMed ID: 36803824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
    Oertel W; Schulz JB
    J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Perspectives on Immune Involvement in Parkinson's Disease Pathogenesis.
    Gate D
    J Parkinsons Dis; 2022; 12(s1):S5-S11. PubMed ID: 35811535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of innate immunity and inflammation in Parkinson´s disease.
    Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A
    Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
    Jiang T; Li G; Xu J; Gao S; Chen X
    Front Immunol; 2018; 9():2047. PubMed ID: 30319601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
    Garretti F; Agalliu D; Lindestam Arlehamn CS; Sette A; Sulzer D
    Front Immunol; 2019; 10():303. PubMed ID: 30858851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk.
    Passaro AP; Lebos AL; Yao Y; Stice SL
    Front Immunol; 2021; 12():676621. PubMed ID: 34177918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.
    Allen Reish HE; Standaert DG
    J Parkinsons Dis; 2015; 5(1):1-19. PubMed ID: 25588354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Contribution of Microglia to Neuroinflammation in Parkinson's Disease.
    Badanjak K; Fixemer S; Smajić S; Skupin A; Grünewald A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation in Parkinson's disease.
    Lee JK; Tran T; Tansey MG
    J Neuroimmune Pharmacol; 2009 Dec; 4(4):419-29. PubMed ID: 19821032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.
    Saponjic J; Mejías R; Nikolovski N; Dragic M; Canak A; Papoutsopoulou S; Gürsoy-Özdemir Y; Fladmark KE; Ntavaroukas P; Bayar Muluk N; Zeljkovic Jovanovic M; Fontán-Lozano Á; Comi C; Marino F
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial antigen presentation: a mechanism linking Parkinson's disease to autoimmunity.
    Fahmy AM; Boulais J; Desjardins M; Matheoud D
    Curr Opin Immunol; 2019 Jun; 58():31-37. PubMed ID: 30904790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application.
    Rege S; Hodgkinson SJ
    Aust N Z J Psychiatry; 2013 Dec; 47(12):1136-51. PubMed ID: 23908311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy in Parkinson's disease: Current status and future directions.
    Chatterjee D; Kordower JH
    Neurobiol Dis; 2019 Dec; 132():104587. PubMed ID: 31454546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses in Parkinson's disease: interplay between central and peripheral immune systems.
    Su X; Federoff HJ
    Biomed Res Int; 2014; 2014():275178. PubMed ID: 24822191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on immunity and inflammation in Parkinson disease pathology.
    Joshi N; Singh S
    J Neurosci Res; 2018 Mar; 96(3):379-390. PubMed ID: 29072332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.